Menlo Therapeutics Inc (MNLO) Stock Price, Quote, News and Overview
NASDAQ:MNLO - Nasdaq -
MNLO Quote, Performance and Key Statistics
1.35
-0.03 (-2.17%)
The current stock price of MNLO is 1.35 null. In the past month the price decreased by -16.41%. In the past year, price decreased by -71.7%.
About MNLO
Company Profile
Menlo Therapeutics Inc. is a late stage biopharmaceutical company. It focused on the development of serlopitant and treatment of chronic itch and chronic refractory cough. The company's product pipeline consists of Prurigo Nodularis Itch, Atopic Dermatitis Itch, Psoriasis Itch and Refractory Chronic Cough which are in clinical stage. Menlo Therapeutics Inc. is headquartered in Redwood City, California.
Company Info
Menlo Therapeutics Inc
520 U.S. HIGHWAY 22 SUITE 204
BRIDGEWATER NJ 08807
CEO: Steven Basta
Phone: 800-775-7936
Menlo Therapeutics Inc / MNLO FAQ
What is the stock price of Menlo Therapeutics Inc today?
The current stock price of MNLO is 1.35 null. The price decreased by -2.17% in the last trading session.
What is the ticker symbol for Menlo Therapeutics Inc stock?
The exchange symbol of Menlo Therapeutics Inc is MNLO and it is listed on the Nasdaq exchange.
On which exchange is MNLO stock listed?
MNLO stock is listed on the Nasdaq exchange.
What is Menlo Therapeutics Inc worth?
Menlo Therapeutics Inc (MNLO) has a market capitalization of 226.38M null. This makes MNLO a Micro Cap stock.
What are the support and resistance levels for Menlo Therapeutics Inc (MNLO) stock?
Menlo Therapeutics Inc (MNLO) has a resistance level at 1.39. Check the full technical report for a detailed analysis of MNLO support and resistance levels.
Should I buy Menlo Therapeutics Inc (MNLO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MNLO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MNLO, evaluating the profitability, health, valuation and growth aspects
- Menlo Therapeutics Inc (MNLO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Menlo Therapeutics Inc (MNLO) Sales and EPS estimates to see what analysts future expectations are.
- Menlo Therapeutics Inc (MNLO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Menlo Therapeutics Inc (MNLO) Insider and Institutional Ownership to learn about the owners and their transactions.
- Menlo Therapeutics Inc (MNLO) Stock Chart to make your own analysis
- Menlo Therapeutics Inc (MNLO) Latest news and press-releases to stay up to date.
Does Menlo Therapeutics Inc (MNLO) stock pay dividends?
MNLO does not pay a dividend.
What is the Price/Earnings (PE) ratio of Menlo Therapeutics Inc (MNLO)?
Menlo Therapeutics Inc (MNLO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.75).
MNLO Technical Analysis
MNLO Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to MNLO. MNLO may be in some trouble as it scores bad on both profitability and health.
MNLO Financial Highlights
Over the last trailing twelve months MNLO reported a non-GAAP Earnings per Share(EPS) of -3.75. The EPS decreased by -32.98% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -1830.82% | ||
| ROA | -188.03% | ||
| ROE | N/A | ||
| Debt/Equity | 0.46 |
MNLO Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 100% to MNLO. The Buy consensus is the average rating of analysts ratings from 7 analysts.